Literature DB >> 16117454

Improved outcomes during cardiac surgery: a multifactorial enhancement of cardiopulmonary bypass techniques.

Cody C Trowbridge1, Alfred H Stammers, G Craig Wood, James D Murdock, Myra Klayman, Bianca R Yen, Edward Woods, Christian Gilbert.   

Abstract

Patients presenting for cardiac surgery with cardiopulmonary bypass (CPB) are more likely to have pre-existing comorbidities, which has resulted in a steady increase in the risk associated with CPB. The resulting challenge has mandated the optimization of perfusion care. The purpose of this study was to retrospectively evaluate the impact of a number of simultaneous, evidence based perfusion care changes on patient outcome. After Institutional Review Board approval, two groups of patients were compared. The control group (n = 317) included all patients undergoing CPB in a 12-month period preceding a multifaceted change in perfusion techniques. The treatment group (n = 259) included all patients undergoing CPB in the 12-month period after the changes, which included the incorporation of updated continuous blood gas monitoring, biocompatible circuitry, updated centrifugal blood propulsion, continuous autotransfusion technology, new generation myocardial protection instrumentation, plasmapheresis, topical platelet gel application, excluding hetastarch while increasing the use of albumin, viscoelastographic coagulation monitoring, and implementing a quantitative quality improvement program. After univariate analysis, propensity scoring and multiple conditional logistical regression were used to control for demographic, preoperative, operative, and postoperative parameters. Results of the primary endpoints revealed a lower mortality rate in the treatment group (4% vs. 9% [95% confidence interval 1.33, 7.72], p = 0.009), lower transfusion rate (51% vs. 59% [1.00, 2.11], p = 0.048), and lower complication rate (55% vs. 65% [1.06,2.19], p = 0.025) despite having similar predicted mortality (11 [2,22] vs. 11[3,22], p = NS) and other preoperative and operative parameters. The lower mortality rate was concurrent with a trend towards a lower incidence of complications, consistent with the differences in primary outcomes. In conclusion, the patients treated after the implementation of a multifactorial improvement plan using evidence based changes in CPB care had decreased complication and mortality rates.

Entities:  

Mesh:

Year:  2005        PMID: 16117454      PMCID: PMC4682533     

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  17 in total

1.  Randomized, controlled trials, observational studies, and the hierarchy of research designs.

Authors:  J Concato; N Shah; R I Horwitz
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

2.  Factors affecting perfusionists' decisions on equipment utilization: results of a United States survey.

Authors:  A H Stammers; B L Mejak; E D Rauch; S N Vang; T W Viessman
Journal:  J Extra Corpor Technol       Date:  2000-03

3.  Cardiopulmonary bypass: Evidence or experience based?

Authors:  Claus Bartels; Anja Gerdes; Jörg Babin-Ebell; Friedhelm Beyersdorf; Udo Boeken; Torsten Doenst; Peter Feindt; Michael Heiermann; Christian Schlensak; Hans-Hinrich Sievers
Journal:  J Thorac Cardiovasc Surg       Date:  2002-07       Impact factor: 5.209

4.  A year in review.

Authors:  Alfred H Stammers
Journal:  J Extra Corpor Technol       Date:  2003-12

5.  A decade of change--risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons.

Authors:  T Bruce Ferguson; Bradley G Hammill; Eric D Peterson; Elizabeth R DeLong; Frederick L Grover
Journal:  Ann Thorac Surg       Date:  2002-02       Impact factor: 4.330

6.  The effects of continuous blood gas monitoring during cardiopulmonary bypass: a prospective, randomized study--Part I.

Authors:  C C Trowbridge; M Vasquez; A H Stammers; K Glowgowski; K Tremain; K Niimi; M Muhle; T Yiang
Journal:  J Extra Corpor Technol       Date:  2000-09

7.  Levels of inflammatory markers in the blood processed by autotransfusion devices during cardiac surgery associated with cardiopulmonary bypass circuit.

Authors:  T Amand; J Pincemail; F Blaffart; R Larbuisson; R Limet; J O Defraigne
Journal:  Perfusion       Date:  2002-03       Impact factor: 1.972

8.  Serum albumin and colloid osmotic pressure in survivors and nonsurvivors of prolonged critical illness.

Authors:  M C Blunt; J P Nicholson; G R Park
Journal:  Anaesthesia       Date:  1998-08       Impact factor: 6.955

9.  Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery.

Authors:  Anne H Kuitunen; Markku J Hynynen; Elina Vahtera; Markku T Salmenperä
Journal:  Anesth Analg       Date:  2004-02       Impact factor: 5.108

10.  Heparin-bonded circuits: clinical outcomes and costs.

Authors:  C B Mahoney
Journal:  Perfusion       Date:  1998-05       Impact factor: 1.972

View more
  5 in total

1.  Antiplatelet drugs: mechanisms and risks of bleeding following cardiac operations.

Authors:  Victor A Ferraris; Suellen P Ferraris; Sibu P Saha
Journal:  Int J Angiol       Date:  2011-03

2.  Implementing change in perfusion practice: quality improvement vs. experimentation?

Authors:  Richard F Newland; Robert A Baker
Journal:  J Extra Corpor Technol       Date:  2009-12

Review 3.  A meta-analysis of platelet gel for prevention of sternal wound infections following cardiac surgery.

Authors:  Bilal H Kirmani; Siôn G Jones; Subir Datta; Edward K Mclaughlin; Andreas J Hoschtitzky
Journal:  Blood Transfus       Date:  2016-04-28       Impact factor: 3.443

Review 4.  CONTRA: Hydroxyethyl starch solutions are unsafe in critically ill patients.

Authors:  Christiane Hartog; Konrad Reinhart
Journal:  Intensive Care Med       Date:  2009-06-17       Impact factor: 17.440

5.  Perfusion quality improvement and the reduction of clinical variability.

Authors:  Alfred H Stammers; Cody C Trowbridge; James Pezzuto; Alfred Casale
Journal:  J Extra Corpor Technol       Date:  2009-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.